Don’t combine drugs for which there is no documented evidence of compatibility and chemical and physical stability in devices for the continuous subcutaneous or intravenous infusion of medications (e.g. Elastomers).
In palliative care it is common practice to administer of a combination of drugs by elastomeric pumps for continuous subcutaneous infusion when patients are unable to take oral medication. Due to incompatibility, some combinations may produce chemical-physical...
Don’t exclude nor postpone the oral or parenteral administration of opioids for the palliative treatment of dyspnoea in patients affected by chronic incurable illness with a limited life expectancy.
According to numerous systematic reviews, oral or parenteral opioids are effective in reducing distress caused by breathlessness in patients with advanced or terminal illness.
Do not use phytoestrogens for menopausal-related sexual symptoms.
There is no strong scientific evidence for the use of phytoestrogens in the treatment of menopausal-related sexual symptoms (e.g. hypoactive sexual desire disorder, excitement disorder, orgasmic disorder, dyspareunia, vaginismus) and/or hot flushes. Biological actions...
Do not prescribe phosphodiesterase-5 inhibitors (PDE5i) in men with erectile dysfunction (ED) without an adequate diagnostic work-up.
Prescribing PDE5i without performing an appropriate diagnostic work-up to detect the ED-associated morbidities represents a missed opportunity. In fact, in ED patients the stratification of cardiovascular risk is simple, non-invasive and can reveal an asymptomatic...The campaign DOING MORE DOES NOT MEAN DOING BETTER – CHOOSING WISELY ITALY is promoted by Italy’s Slow Medicine
Recent Comments